Impact of biological agents and tofacitinib for moderate-to-severe ulcerative colitis on health-related quality of life: a protocol for a network meta-analysis

INTRODUCTION: In the past few years, several options have been proposed as alternative and more effective therapeutic drugs for moderate-to-severe ulcerative colitis (UC), such as biological agents and tofacitinib. Most of the clinical studies related to UC aimed to evaluate the efficacy of the drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xueni, Xu, Huimei, Zhang, Dekui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718413/
https://www.ncbi.nlm.nih.gov/pubmed/37313882
http://dx.doi.org/10.1136/bmjopen-2021-055182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718413/
https://www.ncbi.nlm.nih.gov/pubmed/37313882
http://dx.doi.org/10.1136/bmjopen-2021-055182

Ejemplares similares